The U.S. Food and Drug Administration (FDA), overcoming the White House’s initial opposition, released new safety guidelines Tuesday for drugmakers working for months on developing a Chinese virus vaccine. The move could prevent or delay introducing a potentially safe and effective final product before Election Day and beyond.
Share this: